Drugmakers have flirted with these pilots or partnerships, but few have fully embraced partnerships with digital health startups.
There are dozens of players, including leaders like IBM Watson Health and Verily as well as smaller concerns, lining up to sell pharma access to some sort of data solution.
In short, CEOs can't be afraid to walk away from their most profitable line if another approach may lead to improved long-term outcomes.
When his mother suffered from ovarian cancer a decade ago, Robert Herjavec found himself frustrated by the quality of care she received.
Otsuka, Astellas, Takeda, and Daiichi Sankyo share a degree of adventurousness and forward-mindedness in the digital realm.
Read more to learn what Startup Health's Unity Stoakes and UCB's Greg Cohen, and others have to say about the latest trends for 2017.
The risk of fraud is also very real, especially in an industry that already faces privacy and compliance challenges, one expert says.
There's a reason pharma lags on the programmatic adoption curve: It's a heavily regulated industry, and there are concerns around privacy.
A new survey found that U.S. pharma marketers prefer using social media and mobile apps to reach healthcare providers.
How pharma distributes information to doctors is changing as rapidly as how doctors prefer to receive and process such information
Judges loved the strategy and the comprehensive suite of support available across platforms for the Quitter's Circle.
Judges thought the Cooties Catcher campaign for Purell to help schoolchildren keep their hands clean was brilliant, innovative, and exceptionally well executed.
In the A Thousand Words About NTM campaign, real NTM patients were paired with artists who created original pieces that communicate patients' difficult journey to diagnosis.
Learn six ways to apply this data to new types of highly efficient and effective digital strategies.
Join this live webinar to hear how AbbVie standardized their digital content creation process across brands, accelerating production cycles, eliminating sales re-training, and empowering sales representatives with customized and compliant content.
It's a common refrain in healthcare and among patients, providers, and payers: Despite massive investment, no one has figured out how to change human behavior.
The FTC asks for more info about Pfizer-Allergan deal; the FDA loosens guidelines for abortion-inducing drug; startup to deliver Truvada through an app
Viscira, a digital marketing agency, works with GlaxoSmithKline, Merck, and Genentech, among other life-sciences companies.
Here's my biggest gripe: Innovation teams should be driving innovation for their particular business, not just for marketing and communications.
Perfectionists in the world of pharma marketing can no longer rely on the status quo, given current threats to traditional commercial models and the rise of digital HCP engagement.
The agency announced a partnership with Vencore Health Analytics to help pair rare disease patients with drugmakers.
The Silicon Valley gadget guru who helped define the beyond-the-pill era will talk about embedding nontraditional capabilities into biopharma business models.
They will attempt to develop a new industry standard for digital advertising viewability, a much debated topic that has vexed the broader advertising industry.
Part of LinkedIn's appeal lies in the high level of engagement of its members and the potential for precise targeting of content and talent searches.
Fitbit faces allegations of inaccurate heart monitoring; Viiv Healthcare to collaborate with Janssen; Guardant Health raises funding for its cancer blood tests
Here are the 40 executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.
An initial list of consumer health tech deemed essential by MIT and Harvard doctors is short on pharma-backed apps or services.
The agency will team up with Tsinghua Institute of Health Communication on study on how consumers interact with healthcare content.
A nonprofit institute will soon start producing consumer reviews of digital health tools that have been vetted by Harvard clinicians.
The company "embraces" adverse-event reporting and knows not to expect monetary ROI from unbranded initiatives, says its US-based social media lead.
- Top 25 rare disease brands, by sales
- Five things for pharma marketers to know: Monday, February 13, 2016
- Merck's DTC ad for Keytruda hints at more cancer brands turning to TV
- Five things for pharma marketers to know: Wednesday, February 15, 2017
- Five things for pharma marketers to know: Thursday, February 16, 2017